Visualized Cancer Medicine

Open Access

The first reported case of a patient with small cell lung cancer treated with fan beam computed tomography-guided online adaptive radiotherapy

Shuohan Zheng, Xiaobo Jiang, Sijuan Huang, Xin Yang, Wenpei Cai, Binghuan Li, Shumeng He, Hua Li and Ming Chen

Vis Cancer Med, 4 (2023) 7

Published online: 04 July 2023

DOI: https://doi.org/10.1051/vcm/2023003

Open Access

Semaphorin 4C accelerates disease progression and enables disease detection in breast cancer

Huayi Li, Xin Li, Sen Xu, Yu Xia, Hongfeng Zhang and Qinglei Gao

Vis Cancer Med, 4 (2023) 6

Published online: 31 May 2023

DOI: https://doi.org/10.1051/vcm/2023002

Open Access

Review

Friend or Foe? The fascinating Tudor-SN protein

Xingjie Gao, Lingbiao Xin, Zhi Yao, Olli Silvennoinen and Jie Yang

Vis Cancer Med, 4 (2023) 5

Published online: 07 March 2023

DOI: https://doi.org/10.1051/vcm/2023001

Open Access

Licensing instead of fueling: Glutamine synthetase promotes mitotic progression via a non-metabolic mechanism

Jiang-Sha Zhao, Jing Yang, Zhimin Lu and Yu-Xiong Feng

Vis Cancer Med, 4 (2023) 3

Published online: 17 January 2023

DOI: https://doi.org/10.1051/vcm/2022009

Open Access

Review

Integrin α6 targeted cancer imaging and therapy

Wenbiao Zhang, Jiacong Ye, Xinling Li, Yinghe Li and Guokai Feng

Vis Cancer Med, 4 (2023) 4

Published online: 13 January 2023

DOI: https://doi.org/10.1051/vcm/2022007

Open Access

Review

Functions of glutaminyl cyclase and its isoform in diseases

Yu’e Liu, Yufeng Shi and Ping Wang

Vis Cancer Med, 4 (2023) 1

Published online: 06 January 2023

DOI: https://doi.org/10.1051/vcm/2022008

Open Access

WTX beyond WNT signaling pathway

Qingling Zhang, Qi Hu, Jian Li and Zhirui Lin

Vis Cancer Med, 4 (2023) 2

Published online: 06 January 2023

DOI: https://doi.org/10.1051/vcm/2022006

Open Access

Benefits of precision medicine in lung cancer: experience from a single institution

Na Zhou, Man Jiang and Xiaochun Zhang

Vis Cancer Med, 3 (2022) 4

Published online: 21 October 2022

DOI: https://doi.org/10.1051/vcm/2022005

Open Access

Review

CBP/p300 bromodomain: new promising epigenetic target

Qiuping Xiang, Yang Zhou, Yan Zhang and Yong Xu

Vis Cancer Med, 3 (2022) 3

Published online: 12 September 2022

DOI: https://doi.org/10.1051/vcm/2022004

Open Access

Editorial

Another treatment option for locally advanced hepatocellular carcinoma: Interventional arterial infusion of FOLFOX chemotherapy from the FOHAIC-1 study

Ning Lyu and Ming Zhao

Vis Cancer Med, 3 (2022) E1

Published online: 26 April 2022

DOI: https://doi.org/10.1051/vcm/2022003